SEC Tracker
Get the app

Recursion Pharmaceuticals RXRX

Recursion Pharmaceuticals offers $200M in Class A stock

Securities offering

Form
424B5
Filed
Importance
Routine
  1. $200,000,000 in Class A Common Stock offered
  2. Last reported stock price $3.74 on Oct 14, 2026
  3. Underwriters include Goldman Sachs, Morgan Stanley, and others

Written from the 424B5 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Recursion Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Bausch Health Companies BHC public float $2.0B, Jun 30, 2025
  2. Vericel VCEL public float $2.1B, Jun 30, 2025
  3. Agios Pharmaceuticals AGIO public float $1.9B, Jun 30, 2025
  4. Biocryst Pharmaceuticals BCRX public float $1.9B, Jun 30, 2025
  5. Indivior Pharmaceuticals INDV public float $1.8B, Jun 30, 2025